Bayer, Monsanto Start Asset Sale to get Merger ClearanceAsset sales worth roughly $2.5 billionNovember 30, 2020German drug and crop chemical maker Bayer and U.S. seeds company Monsanto are launching asset sales For the full story click here. RecommendedFeed Mill Renovations & BuildsItalian animal nutrition company breaks ground on Maryland facilityBusiness & MarketsNutrien expands digital platform to streamline farm managementRelated StoriesHomeAAFC Investing in Northern AlbertaHomeDidion Hosts Sustainability EventHomeAshby, MN, Elevator Closes Amid Allegations of Manager MisconductHomeArdent Mills Releases Sustainability Report